Effects of Complete and Partial Loss of the 24S-Hydroxycholesterol-Generating Enzyme Cyp46a1 on Behavior and Hippocampal Transcription in Mouse

Author:

Shu Hong-Jin1,Ziolkowski Luke H.1,Salvatore Sofia V.1ORCID,Benz Ann M.1,Wozniak David F.12,Yuede Carla M.1,Paul Steven M.12,Zorumski Charles F.12,Mennerick Steven12ORCID

Affiliation:

1. Department of Psychiatry, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA

2. Taylor Family Institute for Innovative Psychiatry Research, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA

Abstract

Brain cholesterol metabolic products include neurosteroids and oxysterols, which play important roles in cellular physiology. In neurons, the cholesterol oxidation product, 24S-hydroxycholesterol (24S-HC), is a regulator of signaling and transcription. Here, we examined the behavioral effects of 24S-HC loss, using global and cell-selective genetic deletion of the synthetic enzyme CYP46A1. Mice that are globally deficient in CYP46A1 exhibited hypoactivity at young ages and unexpected increases in conditioned fear memory. Despite strong reductions in hippocampal 24S-HC in mice with selective loss of CYP46A1 in VGLUT1-positive cells, behavioral effects were not recapitulated in these conditional knockout mice. Global knockout produced strong, developmentally dependent transcriptional effects on select cholesterol metabolism genes. These included paradoxical changes in Liver X Receptor targets. Again, conditional knockout was insufficient to recapitulate most changes. Overall, our results highlight the complex effects of 24S-HC in an in vivo setting that are not fully predicted by known mechanisms. The results also demonstrate that the complete inhibition of enzymatic activity may be needed for a detectable, therapeutically relevant impact on gene expression and behavior.

Funder

Mennerick, Zorumski

Mennerick

Publisher

MDPI AG

Reference48 articles.

1. Targeting Cytochrome P450 46A1 and Brain Cholesterol 24-Hydroxylation to Treat Neurodegenerative Diseases;Pikuleva;Explor. Neuroprot. Ther.,2021

2. Study of Cholesterol Metabolism in Huntington’s Disease;Leoni;Biochem. Biophys. Res. Commun.,2014

3. The Potential of CYP46A1 as a Novel Therapeutic Target for Neurological Disorders: An Updated Review of Mechanisms;Alavi;Eur. J. Pharmacol.,2023

4. Neurosteroids and Oxysterols as Potential Therapeutic Agents for Glaucoma and Alzheimer’s Disease;Ishikawa;Neuropsychiatry,2018

5. 24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival;Sun;Neuroscientist,2015

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3